Transaction · 0001061983-26-000088

Malik Fady Ibraham

Malik Fady Ibraham, ER, reported an open-market or private sale at CYTOKINETICS INC involving 3500.000000 shares for an estimated $265370.00. Reported holdings after the transaction were 153902.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SER

CYTKCYTOKINETICS INC

Filing timeAug 18

Trade dateAug 18, 2026

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

$76.09

Pre-filing

1mo ago +5.4%1w ago +0.5%1d ago -0.3%

Returns since

7d +2.8%30d -6.2%90d -6.2%180d -6.2%1y -6.2%

CYTK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

CYTK since 2026-08-18Filed 17 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001061983-26-000088
Transaction date: Aug 18, 2026
Shares: 3.50k sh
Estimated value: -$26.5M
Holdings after: 153k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership

+10score

Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP Research & Development

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001061983-26-000088

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

CYTK